22 May 2013
Keywords: merck, co, diversa, enter, antibody, deal, genomics
Article | 17 January 2005
Genomics group Diversa Corp has entered into a collaboration with fellow USA-based drugmaker Merck & Co for the development of therapeutic
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 January 2005
© 2013 thepharmaletter.com